HIV Webinar

Pharma Intelligence is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.


Thank you for your interest in the Uptake of New, Safer, and Simplified Regimens to Drive HIV Market Growth webinar.

Mr. Haydock & Mr. Haas will use the exclusive information within Datamonitor Healthcare and Biomedtracker to present a view of the market for HIV drugs. Informa Pharma Intelligence forecasts HIV sales revenues to increase in the US and five major EU markets to a peak of $22.7bn in 2024 before generic erosion triggers a market decline.

Your Presenters:

Michael Haydock joined Informa as an analyst in 2012, having achieved a first-class degree in Natural Sciences (Immunology and Virology) from the University of Cambridge. Michael has produced analyses on various antiviral indications including hepatitis B, hepatitis C, and HIV, as well as several vaccine indications. 

Joseph Haas is a senior writer for Informa’s pharmaceutical news publications, with more than eight years covering the biopharmaceutical industry. Joe’s areas of expertise include business development, mergers and acquisitions, infectious diseases and liver diseases, including hepatitis C, hepatitis B and non-alcoholic steatohepatitis (NASH).

Complete the form below to register for this webinar:

Pharma Intelligence. Copyright © 2018 Informa Plc.

This site is owned and operated by Informa plc ("informa") whose registered office is 5 Howick place, London SW1P 1WG. Registered in England and Wales Number 1072954.
Privacy Policy | Terms